Ribonucleotide reductase (RNR)
Clinical / pharmacological. Target of hydroxyurea; allosterically controlled by dNTPs
What it does, reaction by reaction
Pyrimidine De Novo Synthesis (through to UMP, then CTP/dTMP) Nucleotide Metabolism · Cytosol (one mitochondrial step)
UDP → dUDP (route to dUMP)
› Notes
Ribonucleotide reductase (RNR) catalyzes UDP + reducing equivalents → dUDP + oxidized electron-transfer proteins. In humans the reducing equivalents are supplied principally by NADPH through thioredoxin reductase and thioredoxin (or through glutaredoxin/glutathione); RNR is covered mechanistically in the deoxyribonucleotide section.
Showing all 1 reactions.
What accelerates and inhibits it
Regulation is pathway-specific, so each context is listed separately
Deoxyribonucleotide Formation (Ribonucleotide Reductase pathway and thymidylate synthesis)
ATP at the activity site; substrate specificity is directed by ATP/dATP, dTTP, and dGTP at the specificity site
dATP at the activity site (global feedback inhibition); hydroxyurea quenches the radical; iron limitation impairs radical-center assembly
Transcription and activity rise in late G1/S through E2F and proliferative growth-factor signaling; p53-induced RRM2B supports DNA repair under stress.
Recent literature
Nothing is fetched until you ask, so the page stays fast and the request is yours rather than automatic.
Europe PMC · ten most recent, newest first